Literature DB >> 32103886

Functional and Structural Changes of the Retinal Nerve Fiber Layer and Ganglion Cell Complex in Heavy Smokers.

Marwa Abdelshafy1, Ahmed Abdelshafy1.   

Abstract

PURPOSE: To assess the functional and structural changes in the retinal nerve fiber layer (RNFL) and the ganglion cell complex (GCC) in heavy smokers using pattern electroretinogram (PERG), photopic negative response(PhNR) and spectral domain optical coherence tomography (SD-OCT). PATIENTS AND METHODS: Sixty eyes of 30 heavy smokers (at least 15 cigarettes/day for 10 years) (study group) and 60 eyes of 30 age and gender-matched healthy non-smoker subjects (control group) were included. After full ophthalmologic examination (PERG), (PhNR) using RETI-port/scan 21 (Roland Consult, Brandenburg, Germany) and (SD-OCT using Topcon 3D OCT model 2000 FA version.8.30) were tested for all participants. Statistical analysis was performed to compare GCC, RNFL thicknesses, PERG and phNR values between groups.
RESULTS: The mean age was 36.67±4.13 years in the study group and 36.0±4.76 years in the control group. There were no statistical significant differences between the two groups regarding intraocular pressure (p=0.43), axial length (p=0.37), and central corneal thickness (p=0.86). There were significant differences of GCC thickness values between the study group (88.4±6.6 µm) and control group (94.83±5.25 µm) (p<0.001). The mean RNFL values of study and control groups were 97.87±5.88 and 106.43±6.59 µm, respectively (p<0.001). In the study group the superior and inferior quadrants of RNFL were significantly thinner, but there were no significant differences between the two groups in nasal and temporal quadrants. There were no significant differences of PERG-P50 amplitude (p=0.49) and latency (p=0.71); however, PERG-N95 amplitude and latency showed significant differences between the two groups (p<0.001).There were significant differences of phNR amplitude and latency between the two groups (p<0.001). Multiple regression analyses demonstrated that the PhNR, PERG amplitude and latency are the most important determinants for both RNFL and GCC thicknesses.
CONCLUSION: In heavy smokers RNFL thickness was decreased, the PhNR, PERG-N95 amplitudes were diminished and the implicit times were prolonged compared to non-smokers. PhNR and PERG reflect both dysfunction and loss of ganglion cells and their axons.
© 2020 Abdelshafy and Abdelshafy.

Entities:  

Keywords:  GCL; nerve fiber layer; optical coherence tomography; pattern electroretinogram; photopic negative response

Year:  2020        PMID: 32103886      PMCID: PMC7024864          DOI: 10.2147/OPTH.S235892

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

The World Health Organization (WHO) estimated that tobacco could kill around six million individuals each year, including five million deaths due to direct tobacco use and about 600,000 deaths of non-smokers being vulnerable to passive smoking. The increased number of cigarettes smoked per day and the duration of smoking are emphatically affiliated to high mortality and morbidity rate.1 Tobacco smoke consists of more than 4000 synthetic compounds that are harmful to the cardiovascular and respiratory systems. Smoking increases the risk of atherosclerotic and thrombo-embolic complications.2 It also increases the risk of developing many visual pathologies such as glaucoma, cataract, diabetic retinopathy, hypertensive retinopathy, thyroid orbitopathy, age-related macular degeneration (ARMD), ischemic optic neuropathy, keratoconjunctivitis sicca and retinal vein occlusion.3,4 Heavy smoking and excessive nicotine result in direct neurotoxic impact on the optic nerve. This neurotoxic effect may be accompanied by vasoconstriction and reduction of blood flow that lead to ganglion cell and retinal nerve fiber layer (RNFL) loss.5 Previous research reported diminished retinal sensitivity and peripheral scotoma in the visual fields of heavy smokers.6 Spectral domain-optical coherence tomography (SD-OCT) with advanced software (e.g., enhanced depth imaging) generates high resolution cross-sectional images and provides a quantitative measurement of the peripapillary retinal nerve fiber layer (cpRNFL) and ganglion cell-inner plexiform layer complex (GC-IPL).7 The pattern electroretinogram (PERG) is an objective test that provides assessment of the central/macular retinal functions.8 The origins of N95 wave from ganglion cell allow electrophysiological assessment of their function in primary and secondary optic nerve dysfunctions, where particular loss of N95 component can be noticed.9 The photopic negative response (PhNR) is the negative potential that occurs after the b-wave of the ERG. It originates from the retinal ganglion cells (RGC) and their axons so it represents the ganglion cell and inner retinal cell function.10 It can be decreased in diseases that influence the inner retina, including glaucoma and different types of optic neuropathy.11 Previous studies have reported a correlation between the amplitudes and latency of the PhNR with the mean RNFL thickness. This indicates that the RGC function is correlated to RNFL thickness.12 With these advances, ophthalmologists have the chance to evaluate the impact of heavy cigarettes smoking on the retinal nerve fiber layer and ganglion cell layer in more detail. The purpose of this study was to assess the basic morphological and functional changes in RNFL and GCC of heavy smokers in comparison to non-smokers.

Materials and Methods

Patients

This study was conducted in the Ophthalmology Department of Benha University Hospitals in the period between January 2018 and February 2019 after the required ethical approval from the local research ethical committee of Benha Faculty of Medicine. The study followed the basic rules of declaration of Helsinki involving human trials and all participants signed written informed consent. One hundred and twenty eyes of 60 participants were included in this study. They were divided into two groups according to their smoking status; group (A) 30 heavy smokers (defined as subjects who smoke at least 15 cigarettes per day for 10 years) and group (B) 30 age and gender-matched healthy non-smoker participants. The inclusion criteria were patients of both gender, age ranged between 29 and 45 years, best corrected visual acuity of 20/20 or better with spherical refraction ranged from +1.0 to −1.0 dioptre and intraocular pressure less than 21mmHHg. Exclusion criteria were any evidence of systemic disease that was diagnosed upon history taking, general physical examination and laboratory investigations such as; diabetes mellitus, hypertension, multiple sclerosis and Alzheimer’s disease. Subjects with history of glaucoma, eye trauma, Lasik surgery, retinal surgery, previous retinal diseases, and alcohol or drug intake of preparation that could affect the measurements especially systemic vasoactive substances were also excluded.

Ophthalmological Examination

Full ophthalmological examination were performed to all subjects including slit-lamp examination, intraocular pressure measurement (IOP) by Goldmann applanation tonometry, refraction, best-corrected visual acuity (BCVA) and fundus examination. The central corneal thickness (CCT), and axial length (AXL) were measured by the LenStar LS900. SD-OCT (Topcon 3D OCT model 2000 FA version.8.30) was used to measure the peripapillary RNFL and GCC thickness from the macular map scan which calculated automatically through the device’s software. PERG and PhNR were recorded using the RETI-port/scan 21 (Roland Consult, Brandenburg, Germany). The PERG test was performed without Pupils dilation to improve the quality of the retinal image and under photopic condition. Stimulation of both eyes at the same time was used with patient refraction/correction for 100 cm viewing distance. PERG stimulation parameters included the following: large and small black-and-white backward-moving checkerboard stimulus (>15° field of view), >80% contrast, mean luminance 50 (cd/m2), with a check size equals to 1° 2′; and 2 reversals/s. The ground gold disk electrode was placed over the forehead, while the HK-loop electrode was applied into the lower fornix after usage of local anesthesia eye drops and the surface reference electrodes were fixed on the ipsilateral outer canthus skin of each eye. The PERG test was performed following the ISCEV guidelines.13 The PhNR examination was performed following the strict ISCEV Standards for the photopic ERG; including pupil dilation and 10 minutes of light adaptation. Ganzfeld settings were: Background blue 25 cds/m2 (455 nm), red light flash stimulus 0.4 cds/m2 (625 nm), with Inter-flash interval: 1 s. The PhNR amplitude was identified as the difference between the baseline and the trough of the negative wave following the b-wave (Figure 1).11 The implicit time was identified as the time interval from onset of the stimulus and the peak of the negative wave.
Figure 1

The PhNR amplitude calculation.

The PhNR amplitude calculation.

Statistical Analysis

Statistical analysis of the data was performed using the SPSS software version 20. Quantitative information was presented in terms of mean ± SD, while descriptive data were tested using chi-square test. Independent sample t-test and Mann–Whitney U-test were utilized accordingly, whenever applicable, for performing inter-group comparisons. Pearson’s correlation analysis and Regression analyses assessed various factors that could affect the RNFL and GCC thickness. Comparisons were considered significant when (p< 0.05) and highly significant when (p< 0.001).

Results

A total of 120 eyes of 60 participants were included in this study, 60 eyes of 30 heavy smokers as the study group (A) and 60 eyes of 30 non-smokers as the control group (B).

Demographics

Group A consisted of 22 males (73.3%) and 8 females (26.7%) with age ranging from 29 to 44 years, while the control group consisted of 20 males (66.7%) and 10 females (33.3%) with same age range. No statistically significant differences regarding age, gender, visual acuity (VA), BCVA, refraction, IOP, AXL and CCT were found between the two groups (Table 1). Group (A) smoked an average of (36.0 ± 16.95) cigarettes daily with range between 15 and 60 cigarettes. The duration of smoking ranged between 10 and 31 years with mean of (18.0 ± 6.60) years (Table 2).
Table 1

Demographics and Clinical Findings of the Whole Study Population as Well as Comparison Between the Two Groups

Group (A) Smokers Mean ± SDGroup (B) Control Mean ± SDP value
Gender n (%)
 Male22(73.3%)20(66.7%)0.57
 Female8(26.7%)10(33.3%)
Age36.67±4.1336.0±4.760.56
V/A (logMAR)0.053±0.050.03±0.0460.01
BCVA(logMAR)0.00 ± 0.000.00 ± 0.00
SE (dioptre)−0.07±0.63−0.03±0.490.71
AXL (mm)22.54±0.8622.41±0.670.37
CCT (mm)517.5±28.73518.4±28.810.86
IOP (mmHg)14.47±1.8714.2±1.770.43

Abbreviations: VA = visual acuity; BCVA = best corrected visual acuity; SE = spherical equivalent; AXL = axial length; CCT = central corneal thickness; IOP = intra ocular pressure.

Table 2

Description of Smoking Status of Study Group

Mean ± SDRange
Duration of smoking/year18.0±6.6010–31
No of cig/day36.0±16.9515–60
Demographics and Clinical Findings of the Whole Study Population as Well as Comparison Between the Two Groups Abbreviations: VA = visual acuity; BCVA = best corrected visual acuity; SE = spherical equivalent; AXL = axial length; CCT = central corneal thickness; IOP = intra ocular pressure. Description of Smoking Status of Study Group The mean RNFL values showed a statistically significant differences between the study and control groups (p<0.001). Furthermore, superior and inferior quadrants of RNFL were significantly thinner in the study group (p< 0.001 and p< 0.001) respectively, but no significant differences were found in temporal or nasal quadrants (p=0.07 and p=0.37 and) respectively (Table 3). Also, total GCC values were significantly thinner in the study (smokers) group in comparison to control group (p<0.001) (Table 3) (Figure 2). The reduction of GCC thickness was more in males (87.0 ±6.84 µm) than females (92.25 ± 3.96 µm) (p=0.005).
Table 3

Comparison of the RNFL and GCC Thickness Between Smokers and Non- Smokers Participants

Group (A) Smokers Mean ± SDGroup (B) Control Mean ± SDP value
RNFL Thickness
Total97.87±5.88106.43±6.59<0.001**
Inferior107.37±12.58140.07±12.01<0.001**
Nasal89.3±5.7790.37±7.010.37
Superior107.5±14.47140.0±11.09<0.001**
Temporal78.3±5.480.23±6.140.07
GCC Thickness
Inferior87.73±8.5395.77±6.18<0.001**
Superior88.77±7.5494.87±6.28<0.001**
Total88.4±6.694.83±5.25<0.001**

Note: **P value is highly significant.

Abbreviations: RNFL = retinal nerve fiber layer; GCC = ganglion cell complex.

Figure 2

(A) Optical coherence tomography (OCT) of normal control:normal GCC thickness (B) OCT of chronic heavy smoker: there is reduction of GCC thickness (C) PERG of normal control: with normal amplitude and latency (D) PERG of chronic heavy smoker: with decreased amplitude and delay in latency.

Comparison of the RNFL and GCC Thickness Between Smokers and Non- Smokers Participants Note: **P value is highly significant. Abbreviations: RNFL = retinal nerve fiber layer; GCC = ganglion cell complex. (A) Optical coherence tomography (OCT) of normal control:normal GCC thickness (B) OCT of chronic heavy smoker: there is reduction of GCC thickness (C) PERG of normal control: with normal amplitude and latency (D) PERG of chronic heavy smoker: with decreased amplitude and delay in latency. There was no significant difference of PERG-P50 amplitude (p = 0.49) or latency (p = 0.71). However, PERG-N95 amplitude and latency showed significant differences between smokers and non-smokers (p < 0.001) (Table 4). There were significant differences of phNR amplitude and latency between the two groups (p < 0.001) (Table 4).
Table 4

Comparison of PERG and PhNR Parameters Between Smokers and Non-Smoker Participants

Group (A) Smokers Mean ± SDGroup (B) Control Mean ± SDP value
Pattern ERG(PERG)
P50 latency (ms)50.56±1.6150.45±1.530.71
N95 latency (ms)107.39±6.2294.8±3.21<0.001**
P50 amplitude (μV)4.10±0.834.2±0.690.49
N95 amplitude (μV)2.96±1.095.74±0.92<0.001**
Photopic Negative Response(PhNR)
PhNR amplitude(μV)12.43±1.7119.22±1.41<0.001**
phNR implicit time(ms)59.41±2.0252.02±2.39<0.001**

Note: **P value is highly significant.

Abbreviations: PERG = pattern electroretinogram; phNR = photopic negative response.

Comparison of PERG and PhNR Parameters Between Smokers and Non-Smoker Participants Note: **P value is highly significant. Abbreviations: PERG = pattern electroretinogram; phNR = photopic negative response. Significant negative correlation was found between superior, inferior RNFL & GCC thicknesses with PERG-N95 and PhNR latency (p<0.001) (Table 5). On the other hand, there was a significant positive correlation between them with PERG-N95 and PhNR amplitude (p< 0.001). Multiple regression analyses demonstrated that the PhNR, PERG amplitude and latency are the most influencing variables on RNFL and GCC thicknesses (Tables 6 and 7).
Table 5

Correlation Between RNFL, GCC Thickness with Other Variables

RNFL Thickness Smokers (60)SuperiorInferiorTotalInferior GCCSuperior GCCTotal GCC
RPrPRPRPrPrP
PERG/P50 latency0.430.001**0.060.660.070.590.190.160.220.090.280.03
PERG/N95 latency−0.59<0.001**−0.64<0.001**−0.74<0.001**−0.46<0.001**−0.52<0.001**0.020.89
PERG/p50 amplitude0.390.002**0.44<0.001**0.63<0.001**0.48<0.001**0.50<0.001**0.020.90
PERG.N95 amplitude0.47<0.001**0.59<0.001**0.53<0.001**0.49<0.001**0.59<0.001**0.220.099
AXL (mm)−0.170.19−0.280.03−0.260.045−0.0230.86−0.040.76−0.030.82
CCT (mm)−0.100.440.120.350.100.440.130.330.050.680.130.34
PhNR amplitude0.69<0.001**0.63<0.001**0.67<0.001**0.360.005**0.54<0.001**−0.090.49
phNR implicit time−0.58<0.001**−0.61<0.001**−0.63<0.001**−0.390.002**−0.390.002**−0.100.43

Note: **P value is highly significant.

Abbreviations: RNFL = retinal nerve fiber layer; GCC = ganglion cell complex; PERG = pattern electroretinogram; phNR = photopic negative response; AXL = axial length; CCT = central corneal thickness.

Table 6

Stepwise Linear Regression of Superior & Inferior RNFL Thickness with Other Variables

The IndependentUnstandardized Coefficients (B)TSig.95.0% Confidence Interval for B
Lower BoundUpper Bound
Superior RNFL ThicknessPERG/P 50 latency3.5844.5500.0002.0045.163
PERG/N 95 latency−0.446-−1.234-0.223−1.170-0.278
PERG/p50 amplitude−3.702-−1.713-0.093−8.036-0.633
PERG/N95 amplitude2.6311.3630.179−1.240-6.501
phNR amplitude4.6912.9900.0041.5447.838
phNR implicit time0.4600.3540.724−2.144-3.064
F15.91
P value<0.001**
R20.64
Adjusted R20.60
Inferior RNFL ThicknessN 95 latency−1.296.320.001**−1.70.88
PERG/p50 amplitude0.0060.0460.96−4.754-4.083
PERG/N95 amplitude0.2862.140.036*−1.895-5.742
AXL (mm)0.181.810.076−5.364-0.931
phNR amplitude0.3492.270.027*−2.639-4.287
phNR implicit time−0.3342.550.013*−3.813-1.660
F39.95
P value<0.001**
R20.41
Adjusted R20.40

Notes: *P value is significant, **P value is highly significant.

Abbreviations: RNFL = retinal nerve fiber layer; PERG = pattern electroretinogram; phNR = photopic negative response; AXL = axial length.

Table 7

Stepwise Linear Regression of Superior & Inferior GCC Thickness with Other Variables

Inferior GCC ThicknessPERG/N 95 latency−0.092-−0.324-0.747−0.660-0.477
PERG/p50 amplitude4.3872.5870.0120.9877.787
PERG/N95 amplitude2.5001.7140.092−0.425-5.424
phNR amplitude−1.564-−1.280-0.206−4.014-0.886
phNR implicit time−0.777-−0.762-0.450−2.821-1.268
F5.91
P value<0.001**
R20.35
Adjusted R20.29
Superior GCC ThicknessPERG/N 95 latency0.0960.4400.662−0.340-0.532
PERG/p50 amplitude1.3171.0120.316−1.291-3.924
PERG/N95 amplitude4.8454.3310.0002.6027.088
phNR amplitude2.5172.6850.0100.6384.396
phNR implicit time2.2812.9170.0050.7133.849
F11.38
P value<0.001**
R20.51
Adjusted R20.47

Note: **P value is highly significant.

Abbreviations: GCC = ganglion cell complex; PERG = pattern electroretinogram; phNR = photopic negative response.

Correlation Between RNFL, GCC Thickness with Other Variables Note: **P value is highly significant. Abbreviations: RNFL = retinal nerve fiber layer; GCC = ganglion cell complex; PERG = pattern electroretinogram; phNR = photopic negative response; AXL = axial length; CCT = central corneal thickness. Stepwise Linear Regression of Superior & Inferior RNFL Thickness with Other Variables Notes: *P value is significant, **P value is highly significant. Abbreviations: RNFL = retinal nerve fiber layer; PERG = pattern electroretinogram; phNR = photopic negative response; AXL = axial length. Stepwise Linear Regression of Superior & Inferior GCC Thickness with Other Variables Note: **P value is highly significant. Abbreviations: GCC = ganglion cell complex; PERG = pattern electroretinogram; phNR = photopic negative response.

Discussion

Smoking has been known to increase the risk for several serious ocular diseases, such as dry eye, glaucoma, ARMD, Graves ophthalmopathy and cataract.14,15 Smoking causes high oxidative stress with release of the free radicals that produced by these oxidizing agents which lead to cell damage and death by apoptosis.16 Hepsen and Evereklioglu6 demonstrated diminished retinal sensitivity in the visual fields of chronic heavy smokers. Tamaki et al17 reported that heavy cigarette smoking reduce the blood stream tissue velocity and reduce the peripheral vessel dimensions in the choroid and optic nerve head. These findings suggest that chronic smoking might influence the inner retinal layer and retinal ganglion cells. This study was conducted to assess harmful effects of chronic heavy smoking on RNFL and GCC using multiple imaging modalities. We found that the average RNFL thickness was significantly thinner in heavy smokers than the control group. Sub-analysis showed that the significantly affected quadrants were the superior and inferior, while no significant differences were found in temporal or nasal quadrants between the two groups. These variations in the quadrants could be explained by the less structural support of axons in superior and inferior optic disc poles due to larger lamina cribrosa fenestrations in theses quadrants in comparison to nasal and temporal poles resulting in greater damage to ganglion cell axons in these areas. These findings concur with the published data by Dervişoğulları et al,18 they demonstrated that the average RNFL was significantly thinner in smokers compared with non-smokers. Also, measurements of superior and inferior quadrants were significantly reduced in smoker cases, with no significant changes in temporal or nasal quadrants. Demirci et al stated that cigarette smoking may cause significant reduction of RNFL thickness in migraine patients.19 Our results showed that GCC measurements of chronic smokers were much lower than that of non-smokers. This was in accordance with the outcomes reported by Moschos et al20 who demonstrated thinner GCC thickness in smokers. We also found that GCC thickness was more reduced in males than females (p=0.005). This may be due the higher rates of smoking in males than females.21 Further research are required to evaluate gender related differences regarding the effects of heavy smoking on ganglion cell layer. Although El-Shazly et al22 concluded that total RNFL and GCC were not significantly influenced when they compared active and passive smokers, the sub-analysis of the quadrants showed that superior and inferior quadrants of RNFL were thinner in the active smokers than passive smokers, with no change in temporal or nasal quadrants. These findings were fairly similar to our results. The reduction of the RNFL and GCC thickness could be explained by either direct neurotoxic impact on the optic nerve or the decreased blood stream because of the vasoconstrictive impact of nicotine.23 In the present study, PERG-P50 amplitude and latency did not show significant differences between both groups, while PERG-N95 demonstrated statistically significant differences between the smokers and control groups. These results are comparable to studies by El-Shazly et al,22 Gűndogân et al24 and Holder25 which reported that smoking affects PERG amplitude and latency significantly in heavy smokers compared with non-smokers. We also found significant reduction of phNR amplitude and prolonged latency in heavy smokers compared with control group.PERG-N95 and phNR are objective tests for ganglion cell functions.26,27 The phNR arises from the electrical activity of RGC and their axons, so it is a useful diagnostic tool for diseases affecting the inner retina and optic nerve such as glaucoma,28 however the amount of research involving the phNR is insufficient. In heavy smokers group we found a significant positive correlation between RNFL and GCC thickness with PERG-N95 and PhNR amplitude, while the RNFL and GCC thickness were negatively correlated with PERG-N95 and PhNR latency. These outcomes may indicate that smoking affects mainly the RNFL and optic nerve. One limitation of this study was the relatively small sample size. Further examinations and studies involving bigger numbers of samples are needed to measure the influence of heavy smoking on different retinal parameters. In conclusion, RNFL and GCC thickness decrease in chronic heavy smokers, the PhNR and PERG-N95 amplitudes were diminished and the implicit times were delayed in comparison to non-smokers. PhNR and PERG reflect both dysfunction and loss of ganglion cells and their axons.
  27 in total

1.  Retinal pathway origins of the pattern electroretinogram (PERG).

Authors:  Xunda Luo; Laura J Frishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-01       Impact factor: 4.799

2.  Chronic open-angle glaucoma and ocular hypertension. An epidemiological study.

Authors:  R W Morgan; S M Drance
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

3.  The photopic negative response of the flash electroretinogram in primary open angle glaucoma.

Authors:  S Viswanathan; L J Frishman; J G Robson; J W Walters
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

Review 4.  The association between cigarette smoking and ocular diseases.

Authors:  A C Cheng; C P Pang; A T Leung; J K Chua; D S Fan; D S Lam
Journal:  Hong Kong Med J       Date:  2000-06       Impact factor: 2.227

5.  The effect of cigarette smoking on retinal nerve fiber layer thickness in patients with migraine.

Authors:  Seden Demirci; Alime Gunes; Serpil Demirci; Suleyman Kutluhan; Levent Tok; Ozlem Tok
Journal:  Cutan Ocul Toxicol       Date:  2015-01-19       Impact factor: 1.820

Review 6.  The association between cigarette smoking and ocular diseases.

Authors:  Y Solberg; M Rosner; M Belkin
Journal:  Surv Ophthalmol       Date:  1998 May-Jun       Impact factor: 6.048

7.  Effect of Active and Passive Smoking on Retinal Nerve Fibre Layer and Ganglion Cell Complex.

Authors:  Amany Abd El-Fattah El-Shazly; Yousra Ahmed Thabet Farweez; Lamia Salah Elewa; Yasser Abdelmageuid Elzankalony; Botheina Ahmed Thabet Farweez
Journal:  J Ophthalmol       Date:  2017-04-12       Impact factor: 1.909

8.  A Comparison of Gender Differences in Smoking Behaviors, Intention to Quit, and Nicotine Dependence among Thai University Students.

Authors:  Dujrudee Chinwong; Ngamtip Mookmanee; Jongkonnee Chongpornchai; Surarong Chinwong
Journal:  J Addict       Date:  2018-10-24

Review 9.  Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data.

Authors:  Petr Kolar
Journal:  J Ophthalmol       Date:  2014-06-09       Impact factor: 1.909

10.  The Impact of Chronic Tobacco Smoking on Retinal and Choroidal Thickness in Greek Population.

Authors:  Marilita M Moschos; Eirini Nitoda; Konstantinos Laios; Dimitrios S Ladas; Irini P Chatziralli
Journal:  Oxid Med Cell Longev       Date:  2016-01-14       Impact factor: 6.543

View more
  2 in total

1.  HORNBILL: a phase I/IIa trial examining the safety, tolerability and early response of BI 764524 in patients with diabetic retinopathy and diabetic macular ischaemia-rationale, study design and protocol.

Authors:  Victor Chong; Quan Dong Nguyen; Yasir Sepah; Andrea Giani; Elizabeth Pearce
Journal:  Trials       Date:  2022-08-17       Impact factor: 2.728

2.  Living Without a Diagnosis: A Patient's Perspective on Diabetic Macular Ischemia.

Authors:  Jacqueline D Humphreys; Sobha Sivaprasad
Journal:  Ophthalmol Ther       Date:  2022-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.